OnKure Therapeutics
OKUR
Insider trades and stock quote 2024-2026
All insider trades at OnKure Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
6/22/2026
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$4.4 |
$378 |
|
6/22/2026
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$4.4 |
$1,332 |
|
3/23/2026
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$4.2 |
$357 |
|
3/23/2026
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$4.2 |
$1,251 |
|
12/22/2025
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$3.0 |
$258 |
|
12/22/2025
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$3.0 |
$896 |
|
9/22/2025
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$2.6 |
$231 |
|
9/22/2025
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$2.6 |
$795 |
|
6/23/2025
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$2.4 |
$722 |
|
6/23/2025
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$2.4 |
$210 |
|
5/15/2025
|
Sell |
Cormorant Asset Management, Lp |
Other |
$1.9 |
$3,363,023 |
|
5/15/2025
|
Buy |
Acorn Bioventures, L.p. |
Ten Percent Owner |
$1.8 |
$2,590,001 |
|
5/12/2025
|
Sell |
Cormorant Asset Management, Lp |
Ten Percent Owner |
$2.0 |
$48,236 |
|
4/7/2025
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$2.7 |
$4,925 |
|
4/7/2025
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$2.7 |
$1,378 |
|
4/4/2025
|
Sell |
Leverone, Jason A. |
Chief Financial Officer |
$3.3 |
$4,253 |
|
4/4/2025
|
Sell |
Saccomano, Nicholas A. |
President and CEO |
$3.3 |
$1,191 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address